Comparison of Fracture Risk Following Semaglutide Treatment vs Sleeve Gastrectomy
Our results indicate a 26% lower fracture risk for the semaglutide group vs SG, suggesting it may help offset the increased fracture risk typically associated with intentional weight loss. However, further research is needed.
Authors
- Joy Y. Wu (ORCID: https://orcid.org/0000-0002-1897-4503)
- Sun H. Kim (ORCID: https://orcid.org/0000-0003-0895-7491)
- Yasaman Motlaghzadeh (ORCID: https://orcid.org/0000-0002-4740-2731)
- Deborah E. Sellmeyer (ORCID: https://orcid.org/0000-0003-4571-1386)
- C. William Pike (ORCID: https://orcid.org/0000-0002-2166-1559)
- Gavin Hui
- Jairo A. Noreñ
Institutions
- Palo Alto University (US)
- Stanford Medicine (US)
- New York Chiropractic College (US)
- Stanford University (US)
Publication Details
- Journal
- AACE Endocrinology and Diabetes
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1016/j.aed.2025.10.001
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00